George M. Lasezkay, CEO at Clearside Biomedical, Inc. (CLSD), bought 12,000 shares at $1.16 ($14K) on 2019-11-11, disclosed to the SEC on 2019-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CLSD | SELL | 2022-01-20 | $23K | — | Filing → |
| CLSD | SELL | 2022-01-13 | $13K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $23K | — | Filing → |